Extracorporeal photochemotherapy in the treatment of cutaneous T-cell lymphoma

Turkish Journal of Cancer

Volumn 33, Issue 1, 2003, Pages 23-26

  Şentürk, Gonca Boztepe ^a   Şahin, Sedef ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Complications; Cutaneous T cell lymphoma; Extracorporeal photochemotherapy; Mechanisms of action; Predictors of outcome; Procedure

Indexed keywords

METHOXSALEN; PSORALEN;

APHERESIS; ARTICLE; CLINICAL FEATURE; CUTANEOUS T CELL LYMPHOMA; DISEASE COURSE; HUMAN; PHOTOCHEMOTHERAPY; SEZARY SYNDROME; ULTRAVIOLET A RADIATION;

EID: 0041356914     PISSN: 10193103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Edelson RL, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987;316:297-303.
2. Heald P, Rook A, Perez M, et al. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 1992;27:427-33.
3. Zic J, Arzubiaga C, Salhany KE, et al. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1992;27:729-36.
4. Zic J, Stricklin G, Greer J, et al. Long term follow-up with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. J Am Acad Dermatol 1996;35:935-45.
5. Zachariae H, Bjerring P, Brodthagen U, et al. Photopheresis in the red man or pre-sezary syndrome. Dermatology 1995;190:132-5.
6. Armus S, Keyes B, Cahill C, et al. Photopheresis in the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1990;23:898-902.
7. Fraser-Andrews E, Seed P, Whittaker S, et al. Extracorporeal photopheresis in Sezary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone. Arch Dermatol 1998;134:1001-5.
8. Bisaccia E, Gonzalez J, Palangio M, et al. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution. J Am Acad Dermatol 2000;43:263-71.
9. Duvic M, Hester JP, Lemak NA. Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1996;35:573-9.
10. Rook AH, Prystowsky MB, Cassin M, et al. Combined therapy for Sezary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observations. Arch Dermatol 1991;127:1535-40.
11. Gottlieb S, Wolfe T, Fox F, et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alpha: a 10 year experience at a single institution. J Am Acad Dermatol 1996;35:946-57.
12. Dippel E, Schrag ED, Goerdt S, et al. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma. Lancet 1997;350:32-3.
13. Marks DI, Rockman SP, Oziemski MA, et al. Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T-cell lymphoma. J Clin Invest 1990;86:2080-5.
14. Vowels BR, Cassin M, Boufal MH, et al. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 1992;98:686-92.
15. Di Renzo M, Rubegni P, De Aloe G, et al. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. Immunology 1997;92:99-103.
16. Vonderheid EC, Zhang Q, Lessin S, et al. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma. J Am Acad Dermatol 1998;38:207-20.
17. Osella-Abate S, Zaccagna A, Savoia P, et al. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy. J Am Acad Dermatol 2001;44:40-7.